×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
FHTX – foghorn therapeutics inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
FHTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/9
07:00 am
fhtx
Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
Low
Report
Foghorn Therapeutics to Present New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP, EP300 and ARID1B Degrader Programs at the 2026 AACR Annual Meeting
3/14
01:32 am
fhtx
Foghorn Therapeutics (FHTX) was downgraded by Wall Street Zen from "b
Low
Report
Foghorn Therapeutics (FHTX) was downgraded by Wall Street Zen from "b
3/12
07:01 pm
fhtx
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
Low
Report
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by Jefferies Financial Group Inc..
3/12
11:22 am
fhtx
Foghorn Therapeutics (FHTX) had its "outperform" rating reaffirmed by Wedbush. They now have a $10.00 price target on the stock.
Low
Report
Foghorn Therapeutics (FHTX) had its "outperform" rating reaffirmed by Wedbush. They now have a $10.00 price target on the stock.
3/11
04:44 pm
fhtx
Foghorn Therapeutics GAAP EPS of -$1.18 misses by $0.08, revenue of $30.91M misses by $0.31M [Seeking Alpha]
High
Report
Foghorn Therapeutics GAAP EPS of -$1.18 misses by $0.08, revenue of $30.91M misses by $0.31M [Seeking Alpha]
3/11
04:22 pm
fhtx
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook [Yahoo! Finance]
High
Report
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook [Yahoo! Finance]
3/11
04:09 pm
fhtx
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
High
Report
Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook
3/10
08:03 am
fhtx
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
Low
Report
Foghorn Therapeutics (FHTX) had its "buy" rating reaffirmed by HC Wainwright. They now have a $13.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
3/11/2026
04:09 pm
fhtx
foghorn therapeutics inc.
MISS
Report
-12.9%
foghorn therapeutics inc.
11/5/2025
07:00 am
fhtx
foghorn therapeutics inc.
BEAT
Report
16.3%
foghorn therapeutics inc.
5/14/2025
07:00 am
fhtx
foghorn therapeutics inc.
IN-LINE
Report
-3.3%
foghorn therapeutics inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/13
04:01 pm
fhtx
Form 4 Foghorn Therapeutics For: Apr 09 Filed by: GOTTSCHALK ADRIAN
Medium
Report
Form 4 Foghorn Therapeutics For: Apr 09 Filed by: GOTTSCHALK ADRIAN
3/11
04:12 pm
fhtx
Form 10-K Foghorn Therapeutics For: Dec 31
High
Report
Form 10-K Foghorn Therapeutics For: Dec 31
3/11
04:09 pm
fhtx
Form 8-K Foghorn Therapeutics For: Mar 11
High
Report
Form 8-K Foghorn Therapeutics For: Mar 11
2/24
04:03 pm
fhtx
Form 4 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Low
Report
Form 4 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
2/24
04:01 pm
fhtx
Form 3 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Low
Report
Form 3 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
2/23
07:00 am
fhtx
Form 8-K Foghorn Therapeutics For: Feb 23
Low
Report
Form 8-K Foghorn Therapeutics For: Feb 23
2/6
04:01 pm
fhtx
Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
Medium
Report
Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: